Neurological Sciences,
Год журнала:
2020,
Номер
41(6), С. 1437 - 1449
Опубликована: Фев. 12, 2020
Abstract
Background
Many
patients
with
brain
tumours
exhibit
mild
to
severe
(neuro)cognitive
impairments
at
some
point
during
the
course
of
disease.
Social
cognition,
as
an
instance
higher-order
cognitive
functioning,
specifically
enables
initiation
and
maintenance
appropriate
social
interactions.
For
individuals
being
confronted
diagnosis
a
tumour,
impairment
function
represents
additional
burden,
since
those
deeply
depend
on
support
empathy
provided
by
family,
friends
caregivers.
Methods
The
present
study
explores
scientific
landscape
(socio)cognitive
functioning
in
tumour
conducting
comprehensive
bibliometric
analysis
using
VOSviewer.
Web
Science
Core
Collection
database
was
examined
identify
relevant
documents
published
between
1945
2019.
Results
A
total
664
English
titles
functions
retrieved.
Automated
textual
revealed
that
data
available
so
far
focus
three
major
topics
patients:
general
paediatric
cases,
well
psychological
factors
their
influence
quality
life.
research
has
gradually
moved
from
clinical
studies
one
outcome
measures
investigations
interactions
constructs
such
anxiety,
depression
or
fatigue.
Medical,
neurological
neuropsychological
journals,
particular
neuro-oncological
journals
most
articles
authored
relatively
small
network
interconnected
researchers
field.
Conclusion
highlights
necessity
more
cognition
patients.
Objective
Metastatic
breast
cancer
(MBC)
is
associated
with
burdensome
side
effects,
including
cognitive
changes
that
require
ongoing
monitoring.
Cognitive
ecological
momentary
assessments
(EMAs)
allow
for
assessment
of
individual
functioning
in
natural
environments
and
can
be
administered
via
smartphones.
Accordingly,
we
sought
to
establish
the
feasibility,
reliability,
validity
a
commercially
available
EMA
platform.
Methods
Using
prospective
design,
clinical
psychosocial
(cognitive
batteries;
patient
reported
outcomes)
were
collected
at
baseline,
followed
by
28-day
daily
protocol
included
self-ratings
symptoms
mobile
tests
(memory,
executive
functioning,
working
memory,
processing
speed).
Satisfaction
feedback
questions
follow-up
data
collection.
Feasibility
analyzed
using
mixed
descriptive
methods.
Test-retest
reliability
was
examined
intraclass
correlation
coefficients
(ICCs)
each
EMA,
Pearson's
used
evaluate
convergent
between
EMAs
baseline
variables.
Results
Fifty-one
women
MBC
(
n
=
51)
completed
this
study.
High
satisfaction
(median
90%),
low
burden
19%),
high
adherence
rates
(mean
94%),
100%
retention
rate
observed.
ICCs
function,
speed
robust
(>0.90)
ICC
memory
acceptable
(>0.66).
Other
correlational
findings
indicated
strong
all
EMAs.
Conclusion
monitoring
28
days
feasible
MBC,
specific
(mobile
tests;
function
self-ratings)
demonstrating
validity.
Journal of Clinical Oncology,
Год журнала:
2021,
Номер
39(29), С. 3283 - 3292
Опубликована: Авг. 18, 2021
Physical
activity
(PA)
is
a
promising
intervention
for
cancer-related
cognitive
decline,
yet
research
assessing
its
use
during
chemotherapy
limited.
This
study
evaluated
patterns
of
PA
before,
during,
and
after
in
patients
with
breast
cancer
the
association
between
function.
Psycho-Oncology,
Год журнала:
2019,
Номер
28(11), С. 2174 - 2180
Опубликована: Авг. 16, 2019
Cancer
and
its
treatment
are
associated
with
long-term
cognitive
deficits.
However,
most
studies
of
cancer
patients
have
used
traditional,
office-based
evaluations
instead
assessing
in
their
daily
lives.
Recent
research
aging
suggests
that
variability
performance
may
be
a
sensitive
indicator
decline.
Using
ecological
momentary
assessment
(EMA),
we
examined
among
breast
survivors
evaluated
whether
ratings
fatigue
depressed
mood
were
cognition.Participants
47
women
(M
age
=
53.3
years)
who
completed
for
early
stage
6
to
36
months
previously.
Smartphones
preloaded
tests
measuring
processing
speed,
executive
functioning,
memory,
as
well
rating
scales
mood.
Participants
prompted
five
times
per
day
over
14-day
period
complete
EMA
tasks
ratings.Cognitive
was
observed
across
all
three
tasks.
Processing
speed
responses
slower
at
rated
themselves
more
fatigued
than
average
(P
<
.001).
Ratings
not
cognition.This
study
is
the
first
report
lives
treated
cancer.
Performance
worse
on
measure
when
woman
her
greater
own
average.
The
ability
identify
moments
cognition
vulnerable
allow
personalized
interventions
applied
they
needed.
Journal of Cancer Survivorship,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 15, 2025
Abstract
Purpose
Perceived
cancer-related
cognitive
impairment
(CRCI)
has
been
reported
in
prostate
cancer
survivors.
Little
is
known
about
how
CRCI
impacts
occupational
functioning
working-aged
survivors
(PCS).
This
study
aimed
to
investigate
the
association
between
and
PCS.
Methods
Data
from
51
PCS,
who
were
employed
at
time
of
diagnosis,
undergoing
hormonal
treatments
(e.g.,
androgen
deprivation
therapy)
or
‘watchful
waiting’/
‘active
surveillance’,
analysed.
An
online
survey
assessed
using
FACT-Cog
Cognitive
Impairments
(PCI20)
subscale,
EORTC-QLQ-30
two-item
scale,
a
single
‘Yes/No’
item
(i.e.,
‘changes
thinking
memory,
attention)’
experienced
as
treatment
side
effect).
PCS
also
indicated
changes
their
ability
work,
performance
work
duties,
decreased
hours.
Logistic
regression
analyses
examined
relationship
measures
outcomes.
Results
Of
19
(37%)
endorsed
experiencing
effects
treatment.
The
question
was
significantly
associated
with
perceived
perform
duties
same
level.
PCI20
scale
not
any
Conclusion
adverse
important
consider
when
are
making
plans
return-to-work
following
Implications
for
Cancer
Survivors
Prostate
may
experience
changes,
which
impact
ability.
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Март 7, 2025
Background
We
investigated
whether
1-year
trajectories
of
cancer-related
cognitive
decline
(CRCD)
would
be
different
in
patients
with
chemotherapy
combined
immune
checkpoint
inhibitors
(chemoICI
group)
as
compared
alone
(chemo
group).
Methods
Participants
scheduled
or
without
ICI
were
prospectively
recruited
from
three
academic
hospitals
and
followed
up
for
1
year
four
sessions.
Subjective
objective
CRCD
measured
by
Perceived
Cognitive
Impairment
(PCI)
Montreal
Assessment
(MoCA),
respectively.
Primary
endpoints
MoCA
PCI
score
changes
minimal
clinically
important
difference
(MCID),
which
was
defined
threshold
meaningful
impairment
events.
Propensity
matching
(PSM)
performed
group
comparison
using
logistic
regression
covariates
including
age,
cancer
stage,
baseline
scores.
Linear
mixed
models
adjusted
repeated
measures.
Results
Out
1557
PSM
yielded
460
patient
pairs
(1:1).
Mean
scores
both
groups
reached
MCID
at
12-month
session
groups.
In
chemoICI,
significantly
lower
the
session,
6,
9,
sessions
than
chemo
(P<0.05).
One-year
events
risks
0.44
0.56
higher
that
(0.35
0.38,
P<0.01).
Significant
differences
found
mean
event-free
survival
time
irAE
chemoICI
subgroup
analysis.
Conclusions
Our
findings
suggest
combining
ICIs
may
exacerbate
to
alone.
However,
reliance
on
screening
tools
self-reported
measures
limits
definitive
conclusions.
Future
studies
incorporating
comprehensive
neuropsychological
assessments
are
warranted.
This
study
underscores
importance
future
research
better
understand
impact
function.
Psycho-Oncology,
Год журнала:
2022,
Номер
31(8), С. 1294 - 1301
Опубликована: Март 23, 2022
Cognitive
symptoms
are
commonly
reported
among
cancer
patients
and
survivors,
yet
guidance
on
when
self-reported
cognitive
warrant
follow-up
is
lacking.
We
sought
to
establish
cut-off
scores
for
identifying
with
perceived
low
functioning
widely
used
self-report
measures
of
cognition
a
novel
single
item
Change
Score.Adult
diagnosed
invasive
who
had
completed
at
least
one
cycle
chemotherapy
questionnaire
containing
the
EORTC-Cognitive
Function
(CF)
subscale,
Functional
Assessment
Cancer
Therapy-Cognitive
(FACT-COG)
Perceived
Impairment
(PCI)
our
Score
(CCS).
receiver
operating
characteristic
analyses
discriminative
ability
these
against
Patient's
Own
Functioning
Inventory
(PAOFI)
as
reference
standard.
chose
each
measure
that
maximised
both
sensitivity
specificity
CF.We
recruited
294
participants
(55.8%
women,
mean
age
56.6
years)
mixed
diagnoses
(25.5
months
since
diagnosis).
On
CCS,
77.6%
some
change
starting
chemotherapy.
PAOFI
36%
CF.
The
following
identified
cases
CF:
≥28.5
CCS
(75.5%
sensitivity,
67.6%
specificity);
≤75.0
European
Organisation
Research
Treatment
Cancer,
QLQ-C30
scale
(90.9%
57.1%
≤55.1
FACT-COG
PCI-18
(84.8%
76.2%
specificity),
≤59.5
PCI-20
(78.8%
84.1%
specificity).We
found
question
asking
about
has
acceptable
discrimination
between
normal
CF
compared
other
more
comprehensive
symptoms.
Further
validation
work
required.
PLoS ONE,
Год журнала:
2024,
Номер
19(10), С. e0312039 - e0312039
Опубликована: Окт. 17, 2024
Cognitive
impairment
is
common
in
haemodialysis
patients
and
associated
with
adverse
health
outcomes.
This
may
be
due
to
cognitive
impairments
interfering
daily
functioning
self-care,
but
evidence
limited.
cross-sectional
study
aims
explore
the
interrelationships
between
cognition
functional
outcomes
patients.
Psycho-Oncology,
Год журнала:
2023,
Номер
32(8), С. 1298 - 1305
Опубликована: Июнь 28, 2023
Abstract
Objective
Subjective
reports
of
cancer‐related
cognitive
impairment
often
far
exceed
that
documented
using
in‐person
neuropsychological
assessment.
This
study
evaluated
whether
subjective
cognition
was
associated
with
real‐time
objective
performance
in
daily
life
versus
on
an
battery,
as
well
fatigue
and
depressed
mood.
Methods
Participants
were
47
women
(M
age
=
53.3
years)
who
completed
adjuvant
treatment
for
early‐stage
breast
cancer
6–36
months
previously.
During
assessment,
participants
a
battery
questionnaires
cognition,
fatigue,
Over
14
days,
responded
to
up
5
prompts
assessed
processing
speed
memory
self‐reported
ratings
mood
fatigue.
In
the
evenings,
rated
their
day
reported
lapses
(e.g.,
forgetting
word).
Results
worse
mood,
but
did
not
exhibit
poorer
performance.
Women
more
demonstrate
cognition.
Finally,
at
end
demonstrated
better
(
p
0.001),
visuospatial
skills
's
≤
0.02).
Conclusion
consistently
Specific
related
suggests
incorporating
may
help
clinicians
identify
those
objectively
measured
impairment.